![Philip R. Tracy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philip R. Tracy
Direttore/Membro del Consiglio presso Viamet Pharmaceuticals Corp.
Posizioni attive di Philip R. Tracy
Società | Posizione | Inizio | Fine |
---|---|---|---|
Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP
![]() Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP Miscellaneous Commercial ServicesCommercial Services Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP provides legal services. The private company is based in Raleigh, NC. | Consigliere Generale | 06/01/2014 | - |
Corporate Officer/Principal | 06/12/2012 | 06/01/2014 | |
Intersouth Associates V LLC | Direttore/Membro del Consiglio | - | - |
Intersouth Associates IV LLC | Direttore/Membro del Consiglio | - | - |
Viamet Pharmaceuticals Corp.
![]() Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Direttore/Membro del Consiglio | 01/01/2015 | - |
Independent Dir/Board Member | 01/01/2015 | - |
Storia della carriera di Philip R. Tracy
Precedenti posizioni note di Philip R. Tracy
Società | Posizione | Inizio | Fine |
---|---|---|---|
ALIMERA SCIENCES, INC. | Direttore/Membro del Consiglio | 01/01/2004 | 06/11/2009 |
Presidente | 06/11/2009 | 06/05/2015 | |
Independent Dir/Board Member | 04/07/2011 | 06/05/2015 | |
Burroughs Wellcome | Amministratore Delegato | 01/01/1974 | 01/01/1995 |
Presidente | 01/01/1974 | 01/01/1995 | |
Viamet Pharmaceuticals, Inc.
![]() Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Direttore/Membro del Consiglio | - | - |
The Burroughs Wellcome Fund
![]() The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Direttore/Membro del Consiglio | - | - |
Intersouth Partners
![]() Intersouth Partners Investment ManagersFinance Intersouth Partners (Intersouth Partners) is a venture capital firm founded in 1985 by Dennis Dougherty and Roy Rodwell. The firm is headquartered in Durham, North Carolina. | Investitore di Private Equity | 01/01/1997 | - |
░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Philip R. Tracy
University of Nebraska | Undergraduate Degree |
George Washington University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 12 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 7 |
Independent Dir/Board Member | 3 |
Chairman | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ALIMERA SCIENCES, INC. | Health Technology |
Aziende private | 9 |
---|---|
Argos Therapeutics, Inc.
![]() Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Intersouth Partners
![]() Intersouth Partners Investment ManagersFinance Intersouth Partners (Intersouth Partners) is a venture capital firm founded in 1985 by Dennis Dougherty and Roy Rodwell. The firm is headquartered in Durham, North Carolina. | Finance |
Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP
![]() Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP Miscellaneous Commercial ServicesCommercial Services Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan LLP provides legal services. The private company is based in Raleigh, NC. | Commercial Services |
Burroughs Wellcome | |
The Burroughs Wellcome Fund
![]() The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous The Burroughs Wellcome Fund is a private foundation located in Research Triangle Park, NC. The private company's mission is to serve and strengthen society by nurturing a diverse group of leaders in biomedical sciences to improve human health through education and powering discovery in frontiers of greatest need. The CEO of the company is Louis J. Muglia. | Miscellaneous |
Intersouth Associates V LLC | |
Intersouth Associates IV LLC | |
Viamet Pharmaceuticals, Inc.
![]() Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Health Technology |
Viamet Pharmaceuticals Corp.
![]() Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Philip R. Tracy
- Esperienza